PUBLISHED FOR OPPOSITION
on 03 Dec 2024
Last Applicant/ Owned by
6175 Nancy Ridge Dr
San Diego
CA
92121
Serial Number
98459161 filed on 20th Mar 2024
Registration Number
N/A
Correspondent Address
Aaron D. Hendelman
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
IMPERA MEDICINES
research and development services in the fields of immunology and oncology; research and development services in the field of cardiometabolic diseases; medical research in the field of oncology; medical research in the field of immunology; medical research in the field of cardiometabolic diseases; research, development, engineering and testing services in the field of pharmaceuticals for the treat Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
research and development services in the fields of immunology and oncology; research and development services in the field of cardiometabolic diseases; medical research in the field of oncology; medical research in the field of immunology; medical research in the field of cardiometabolic diseases; research, development, engineering and testing services in the field of pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, cardiometabolic, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [036]
Insurance & Financial Services
investment consultancy for biotechnology companies; investment management for biotechnology companies; financial services, namely, investment management and advisory services in the field of biotechnology; intellectual property venture fund management services in the field of biotechnology
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
medicinal preparations for the treatment of infectious diseases and for use in oncology; biological preparations for the treatment of cancer; anti-cancer preparations; medicinal preparations for the treatment of cardiometabolic diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cardiometabolic diseases; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, cardiometabolic, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [035]
Advertising, Business & Retail Services
Business consultancy in the field of biotechnology; professional business consulting for biotechnology companies; business consulting, business management and providing information in the biotechnology business field; business services, namely, assisting the owners of intellectual property and intangible assets in the field of biotechnology in finding investors
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98459161
Mark Type
No Service Mark
Attorney Docket Number
No 66625-TM1001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 03rd Dec 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 03rd Dec 2024 | PUBLISHED FOR OPPOSITION |
| 27th Nov 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 11th Nov 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 04th Oct 2024 | EXAMINER'S AMENDMENT ENTERED |
| 04th Oct 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 04th Oct 2024 | EXAMINERS AMENDMENT E-MAILED |
| 04th Oct 2024 | EXAMINERS AMENDMENT -WRITTEN |
| 28th Sep 2024 | ASSIGNED TO EXAMINER |
| 16th Aug 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |